Vertaling van "health and illness which refer directly " (Nederlands → Frans) :

In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.
In order to regulate the quality and relevance of messages to the public, a prior licence is required for radio and TV information campaigns about human health and illness which refer directly or indirectly to medicines. This licence is normally issued by the Minister responsible following advice from the Commission for the supervision of advertising for medicines for human use.

To check the quality and relevance of the messages conveyed to the public, a preliminary check was introduced in 2007 for radio/ TV information campaigns about human health and human diseases that refer directly or indirectly to medicines
To check the quality and relevance of the messages conveyed to the public, a preliminary check was introduced in 2007 for radio/ TV information campaigns about human health and human diseases that refer directly or indirectly to medicines

1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines
1974 on the opening, transfer and merger of retail pharmacies Royal decree of 9 July 1984 on the provision of information and advertising relating to medicines Royal decree of 11 January 1993 determining the conditions under which medicines for human use may be supplied in sample form Royal decree of 7 April 1995 on the provision of information and advertising relating to medicines for human use Royal decree of 15 July 1997 on active implantable medical devices, transposing Directive 90/385 EEC (AIMD) Royal decree of 19 December 1997 on the control and analysis of the raw materials used by dispensing chemists Royal decree of 18 March 1999 on medical devices, transposing Directive 93/42/EEC of 14 June 1993 (MDD) Royal decree of 11 July 2003 determining the conditions under which medicines for veterinary use may be supplied in sample form Law of 16 December 2004 modifying the regulations on combating abuses in the promotion of medicines Royal decree of 10 June 2006 establishing the report point referred to in Article 10, § 5, of the law of 25 March 1964 on medicines Royal decree of 23 November 2006 implementing Article 10, § 3, of the law of 25 March 1964 on medicines Royal decree of 25 February 2007 recognising the institutions referred to in Article 10 § 3 of the law of 25 March 1964 on medicines

Inleiding De World Health Organization (WHO) gaf in 2002 de volgende definitie van palliatieve zorg: ‘Palliative care is an approach to care which improves quality of life of patients and their families facing life threatening illness, through the prevention and relief of suffering by means of identification and impeccable assessment and treatment of pain and other problems, physical, psychosocial and spiritual’.
Introduction En 2002, l’Organisation Mondiale de la Santé (OMS) a revu sa définition des soins palliatifs: « Les soins palliatifs cherchent à améliorer la qualité de vie des patients et de leur famille, face aux conséquences d’une maladie potentiellement mortelle, par la prévention et le soulagement de la souffrance, identifiée précocement et évaluée avec précision, ainsi que le traitement de la douleur et des autres problèmes physiques, psychologiques et spirituels qui lui sont liés».

A European regulation that has entered into force on 1 July 2004 stipulates that, in order to inform the consumer of possible health risks, the labelling of beverages that contain caffeine in a proportion in excess of 150 mg/l should contain the mention “high caffeine content” followed by the caffeine content expressed in mg/100 ml in the same field of vision as the name under which the product is sold (Directive 2002/67/EC).
Enfin, une réglementation européenne, entrée en vigueur au 1er juillet 2004, stipule que l’étiquetage de boissons contenant plus de 150 mg de caféine par litre doit comporter la mention « teneur élevée en caféine » et la mention de sa quantité (en mg/100 ml) dans le même champ de vision du produit afin d’avertir le consommateur des risques possibles pour la santé (Directive 2002/67/CE).

In chapter 7 of “Self-directed violence”, the WHO world report on violence and health measures the extent of the phenomenon of fatal suicidal behaviour by comparing the figures in different countries and regions (75 areas) for which these data are available, on the basis of the most recent year available (between 1990 and 2000)
Dans son chapitre 7 « la violence dirigée contre soi-même », le Rapport mondial sur la violence et la santé de l’OMS, mesure l’ampleur du phénomène du comportement suicidaire fatal, en comparant les taux dans différents pays et régions (75 zones) pour lesquels on dispose de ces données, sur base de l’année la plus récente (entre 1990 et 2000).